Rivastigmine Tartrate
Rivastigmine Tartrate Capsules, USP These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES, USP safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES, USP. RIVASTIGMINE tartrate capsules, USP for oral use Initial U.S. Approval: 2000
2bb5e0d6-f677-4021-9888-3ff90979ef7d
HUMAN PRESCRIPTION DRUG LABEL
Oct 6, 2023
Chartwell RX, LLC
DUNS: 079394054
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
Rivastigmine Tartrate
Product Details
FDA regulatory identification and product classification information